Biological markers and possibilities for predicting therapeutic results in schizophrenia: A methodological contribution

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 4, 2002, Pages 683-691

  Češková, Eva ^a   Drybčák, Pavel ^b   Lorenc, Miroslav ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b Military Technical Institute of Protection   (Czech Republic)

Author keywords

Biological markers; Computer tomography; Cortisolemia; Prediction of treatment response; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER; AMISULPRIDE; ANTIPARKINSON AGENT; DEXAMETHASONE; HALOPERIDOL; PERPHENAZINE; RISPERIDONE; SULPIRIDE; TRANQUILIZER;

ADULT; ARTICLE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; DISCRIMINANT ANALYSIS; ELECTROENCEPHALOGRAPHY; FORECASTING; HUMAN; MALE; MIDDLE AGED; RADIOGRAPHY; SCHIZOPHRENIA; STATISTICS; ATTENTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEMORY; METHODOLOGY; OUTPATIENT CARE; PREDICTION; PROLACTIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; RATING SCALE; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; DISCRIMINANT ANALYSIS; ELECTROENCEPHALOGRAPHY; FORECASTING; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; TOMOGRAPHY, X-RAY COMPUTED; HUMAN; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0036016287     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00318-9     Document Type: Article

References (44)

1. Neurologic abnormalities in schizophrenia
2. Ventricular enlargement in schizophrenia, definition and prevalence
3. Prediction research of neuroleptic treatment outcome in schizophrenia - State of the art 1978-1993
4. Neuroendocrine differences among subtypes of schizophrenic disorder?
5. Cerebral ventricular enlargement and neuroleptic response in chronic schizophrenia: Preliminary findings with risperidone
6. The temporolimbic system theory of positive schizophrenic symptoms
7. Course of illness and predictors of outcome in chronic schizophrenia: Implications for pathophysiology
8. Význam biologických markerů v diagnostice a predikci výsledků akutní léčby
9. The change of biological markers and treatment efficacy in schizophrenia
10. Learning from outcome studies: Toward a comprehensive biological-psychological understanding of schizophrenia
11. Dexamethasone suppression test in depression and other psychiatric illness
12. Pretreatment EEG predicts short-term response to haloperidol treatment
13. Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder
14. Abnormal dexamethasone suppression test results in chronic schizophrenic patients
15. Are schizophrenic with abnormal dexamethasone suppression test results a distinct subgroup?
16. Prognostic scale for chronic schizophrenia
17. Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia
18. The relationship of structural brain imaging parameters to antipsychotic treatment response: A review
19. Prediction research of outcome in neuroleptic treatment - Definitions and concepts
20. First episode schizophrenia the importance of compliance and preserving cognitive function
21. Negative symptoms of schizophrenia and the dexamethasone suppression test
22. Neuropsychological prediction of treatment efficacy and one-year outcome in schizophrenia
23. Neurological soft signs in neuroleptic naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects
24. CGI. Clinical global impression
25. Significance and meaning of neurological soft signs in schizophrenia
26. The dexamethasone suppression test in newly hospitalized schizophrenic patients
27. Regional cortical anatomy and clozapine response in refractory schizophrenia
28. Negative symptoms at discharge and outcome in schizophrenia
29. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
30. Schizophrenia with good and poor outcome: I. Early clinical features, response to neuroleptics and signs of organic dysfunction
31. Hirnoatrophie
32. Association between regional brain volumes and clozapine response in schizophrenia
33. Effects of clozapine on cognitive function in schizophrenia
34. Predictors of outcome in schizophrenia: The concept of time
35. The vulnerability of hippocampus to protective and destructive effects of glucocorticoids in relation to stress
36. Prolactin response to D-fenfluramin challenge test as a predictor of treatment response to haloperidol in acute schizophrenia
37. The psychobiology of the acute schizophrenic episode
38. Temporal stability of neurological signs in first episode psychotic patients
39. Can computerised tomography be used to predict early treatment response in schizophrenia?
40. Outcome of schizophrenia in relation to brain abnormalities
41. A selective review of biological markers in schizophrenia
42. CT scan abnormalities and outcome of chronic schizophrenia
43. Cognitive function in schizophrenia